Early Emergence of HDL Oxidation Across the Body Mass Index Spectrum in Patients with Suspected Coronary Artery Disease
Open Access
- 24 August 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7570
Abstract
Obesity, commonly defined by body mass index (BMI), promotes cardiovascular disease through chronic inflammation and oxidative stress, which impair high-density lipoprotein (HDL) function and favor oxidative modification. Oxidized HDL (HDLox) may link adiposity to cardiovascular risk. However, the association between BMI and HDLox across the adiposity spectrum remains unclear. We therefore examined this relationship in a Coronary-Suspected Cohort. This study included 1227 consecutive patients undergoing elective coronary angiography. Participants were stratified into five predefined BMI categories. HDLox was quantified using a validated fluorometric assay assessing HDL lipid peroxide content. Associations between BMI and HDLox were analyzed using univariable and multivariable linear regression across the full BMI range and within a restricted BMI interval (15–35 kg/m2). HDLox levels were significantly higher in overweight and obese individuals compared with normal-weight participants (p = 0.002 and p < 0.001). HDLox increased from normal weight to obesity class I (BMI 30–34.9 kg/m2) and plateaued at higher BMI levels, indicating a non-linear relationship. In the overall cohort, BMI showed a weak but significant association with HDLox (β = 0.064, p = 0.024). Within the restricted BMI interval, the association was more pronounced (β = 0.158, p < 0.001). In multivariable models, BMI, high-sensitivity C-reactive protein, and male sex remained independently associated with HDLox, whereas traditional cardiovascular risk factors were not. HDL oxidation increases early during weight gain and may represent a functional marker linking adiposity-related inflammation and oxidative stress to cardiovascular vulnerability.Keywords
All Related Versions
Funding Information
- Brandenburg Medical School Theodor Fontane
- BIOX Stiftung, Bochum, Germany
- NIH (R01AG059501)
- European Union’s Horizon 2020 Research and Innovation Program (739593)
- Deutsche Forschungsgemeinschaft (HA 7512/2-4)
- Deutsche Forschungsgemeinschaft (HA 7512/2-1)
- Innovation Forum program of the Medical Faculty (IF-023-22)
- Innovation Forum program of the Medical Faculty (IF-034-22)
- Deutsche Herzstiftung
- Else-Kröner-Fresenius Foundation
- Hector Stiftung
This publication has 49 references indexed in Scilit:
- Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection fractionClinical Research in Cardiology, 2025
- Oxidized high-density lipoprotein associates with atrial fibrillationHeart Rhythm, 2023
- Beyond Coronary Calcification, Family History, and C-Reactive ProteinJACC, 2016
- Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: Does size matter?Atherosclerosis, 2015
- Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid AssociationJournal of Clinical Lipidology, 2013
- Changes in Inflammatory Biomarkers Across Weight Classes in a Representative US Population: A Link Between Obesity and InflammationJournal of Gastrointestinal Surgery, 2009
- Obesity and Cardiovascular DiseaseJACC, 2009
- High-density lipoprotein: Antioxidant and anti-inflammatory propertiesCurrent Atherosclerosis Reports, 2007
- Overweight and Obesity as Determinants of Cardiovascular RiskArchives of internal medicine (1960), 2002
- Elevated C-Reactive Protein Levels in Overweight and Obese AdultsJAMA, 1999